Stay updated with breaking news from Forerunner Ventures Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) rose 5.7% on Monday after an insider bought additional shares in the company. The company traded as high as $22.10 and last traded at $21.97. Approximately 2,810,538 shares changed hands during trading, a decline of 59% from the average daily volume of 6,811,084 […]
Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) insider Soleil Boughton sold 2,502 shares of the company’s stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $17.33, for a total transaction of $43,359.66. Following the transaction, the insider now directly owns 156,855 shares […]
Hims & Hers Health (NYSE:HIMS – Free Report) had its price objective hoisted by Canaccord Genuity Group from $20.00 to $24.00 in a research report sent to investors on Wednesday, Benzinga reports. The brokerage currently has a buy rating on the stock. HIMS has been the topic of several other research reports. Leerink Partnrs reiterated […]
Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report)’s share price gapped down before the market opened on Wednesday following insider selling activity. The stock had previously closed at $17.56, but opened at $17.11. Hims & Hers Health shares last traded at $16.71, with a volume of 1,528,158 shares traded. Specifically, insider Soleil Boughton […]
Jefferies Financial Group reiterated their hold rating on shares of Hims & Hers Health (NYSE:HIMS – Free Report) in a report issued on Tuesday, Marketbeat.com reports. They currently have a $15.00 target price on the stock, down from their prior target price of $17.00. HIMS has been the subject of a number of other reports. […]